Strides Shasun receives USFDA approval for Cetirizine Softgel Capsules

24 Jul 2017 Evaluate

Strides Shasun has received an approval from the United States Food & Drug Administration (USFDA) for Cetirizine Hydrochloride Capsules, 10 mg (Liquid Filled Capsules).  According to IRI data, the US market for Cetirizine Hydrochloride Capsules (Softgel) is approximately $60 million, with only one other generic player.

The product will be manufactured at the company’s flagship facility at Bangalore and marketed by Strides Pharma Inc. in the US market. The product is ready for launch immediately and as in the case of OTC products, the market formation takes time and the company expects to have an important market share in approximately six months. This is the first approval for a Softgel product after the recent USFDA inspection at the company’s Bangalore facility.

Cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction.


Strides Pharma Scien Share Price

806.70 10.50 (1.32%)
29-Jan-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1596.05
Dr. Reddys Lab 1198.50
Cipla 1317.50
Zydus Lifesciences 887.00
Lupin 2118.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×